Ativan (Lorazepam) Withdrawal and Side Effects: What the Research Shows
September 5, 2026
Benzodiazepines in the Elderly: Falls, Memory, and How to Come Off Them After 65
September 5, 2026
The Ashton Manual, Explained
Johnny Tabaie, Founder & CEO, Holistic Sanctuary·Medically reviewed by 
Dr. Jose A. Jimenez, MD, Medical Director·Published · Last medically reviewed Twelve years of a Newcastle withdrawal clinic, written down in 1999 so people who could not get there could taper safely. What the Ashton Manual actually says, chapter by chapter, and what has changed since.
Read This Part First
The Ashton Manual is the most important document ever written for a person who wants to come off a benzodiazepine, and almost nobody who is handed it has time to read all of it. It is long, it is British, it was written in 1999 and revised in 2002, and it assumes a reader who is frightened and a prescriber who is skeptical.
This page explains the Ashton Manual chapter by chapter: who wrote it and why, what it says about how benzodiazepines cause dependence, how its equivalence table works, why slow is the whole method, what diazepam substitution is and when it is used, what its withdrawal schedules look like, what it says about symptoms and the long tail, what has changed since 2002, and how we use it here.
The non-negotiable first, in Ashton’s own spirit: do not stop a benzodiazepine abruptly and do not run a taper on your own. The FDA’s 2020 boxed warning states that abrupt discontinuation or rapid dose reduction can cause withdrawal reactions that are life-threatening, including seizures. The manual is a guide to a supervised taper, not a substitute for the physician who supervises it. If you are thinking about suicide, call or text 988.
Who Heather Ashton Was
Chrystal Heather Ashton, 1929 to 2019, was Emeritus Professor of Clinical Psychopharmacology at the University of Newcastle upon Tyne. From 1982 to 1994 she ran a benzodiazepine withdrawal clinic at Newcastle’s Royal Victoria Infirmary, at a time when the drugs were still widely described as harmless, and she watched her patients come off them slowly, one at a time. Everything in the Ashton Manual comes from that room. It is not a review of the literature; it is twelve years of clinical observation written down so that people who could not get to Newcastle could use it.
The manual, whose formal title is Benzodiazepines: How They Work and How to Withdraw, was written by request in 1999 for readers in the United States who could not find advice anywhere else, revised in August 2002, supplemented in April 2011, and has been translated into eleven languages. It is published free on benzo.org.uk. Its overall message, in Ashton’s words, is that most long-term benzodiazepine users who wish to can withdraw successfully and become happier and healthier as a result. She was not a campaigner against benzodiazepines. She was a campaigner against keeping people on them for years and then stopping them fast.
Chapter I: Why Benzodiazepines Cause Dependence
The first chapter of the Ashton Manual explains the mechanism in plain language. Benzodiazepines amplify GABA, the brain’s main inhibitory neurotransmitter, at the GABA-A receptor; that is why they calm anxiety, relax muscle, prevent seizures and produce sleep. With regular use the brain compensates by reducing its own sensitivity to GABA, which is tolerance: the same dose does less, and the anxiety the drug was prescribed for returns underneath it. Ashton notes that tolerance develops at different rates for different effects, quickly for sleep, more slowly for anxiety, and that cognitive effects may not fully clear.
The consequence is dependence, and the Ashton Manual is blunt about how fast it arrives: psychological and physical dependence can develop within a few weeks or months of regular or repeated use. She distinguishes therapeutic-dose dependence, the ordinary patient on an ordinary prescribed dose for months or years who cannot stop, from misuse, and she estimates that fifty to a hundred percent of long-term users have difficulty stopping because of withdrawal symptoms.
She also records the British Committee on Safety of Medicines’ 1988 advice that benzodiazepines should in general be reserved for short-term use, two to four weeks only. Most of the people who arrive here have been on them for years.
The Equivalence Table
The most quoted part of the Ashton Manual is Table 1, which lists each benzodiazepine’s approximate dose equivalent to 10 mg of diazepam alongside its half-life. The values that matter most for the people who read this site: 0.5 mg of alprazolam, 0.5 mg of clonazepam and 1 mg of lorazepam are each roughly equivalent to 10 mg of diazepam; 20 mg of temazepam and 20 mg of oxazepam are as well. Half-lives run from six to twelve hours for alprazolam and ten to twenty for lorazepam up to eighteen to fifty for clonazepam and up to two hundred hours for diazepam, counting its active metabolite.
The table does two jobs. It shows people how large their “small” dose really is, since 2 mg of Xanax a day is about 40 mg of diazepam, and it makes substitution arithmetic possible. Ashton is careful to say the values are approximate and that individual variation is large; the table is a starting point for a physician, not a conversion chart for a kitchen table. Our pages on the Xanax taper, the Klonopin taper and Ativan withdrawal each work through what those equivalents mean in practice.
Chapter II: Slow Is the Whole Method
Chapter II is the heart of the Ashton Manual, and its central sentence is that the precise rate of withdrawal is an individual matter. Ashton says directly that the classic six-week withdrawal period adopted by many clinics and doctors is much too fast. Her rough guide, from her worked example starting at 40 mg of diazepam a day, is to reduce by 2 mg every one to two weeks until 20 mg, then by 1 mg every week or two, which takes thirty to sixty weeks in that example.
She adds that many people have taken a year or more to complete the withdrawal, and that whether it takes six, twelve or eighteen months is of little significance if you have taken benzodiazepines for a matter of years.
Three principles run through the chapter. The dose is reduced in small steps and the person holds at each step until it has settled; the reductions get smaller as the dose gets lower, because the last milligrams are proportionally the largest cuts; and the schedule is adjusted to the person, never the person to the schedule. She also addresses the fear that drives most failed tapers, the fear that the anxiety returning after a cut means the original illness is back: in the Ashton Manual, that return is expected, it is a withdrawal phenomenon, and it passes if the dose is held rather than raised.
Diazepam Substitution, Explained
The Ashton Manual’s most distinctive recommendation is the gradual substitution of diazepam for shorter-acting benzodiazepines before tapering. Her reasoning is pharmacological. With a short-acting drug like alprazolam or lorazepam it is not possible to achieve a smooth decline in blood and tissue concentrations; the drug’s level rises and falls with every dose, and a taper is a series of cliffs. Diazepam, with a half-life of up to two hundred hours, gives a smooth, gradual fall in blood level. And it comes in 2 mg tablets that are scored and easily halved into 1 mg doses, so reductions can be made in steps no other formulation allows.
The substitution is done one dose at a time over weeks, replacing part of the short-acting drug with its diazepam equivalent, holding, then replacing the next part, until the person is fully on diazepam and the taper proper begins. Done carelessly, as a single overnight swap, it can itself provoke withdrawal, which is why the manual gives it a schedule rather than a sentence.
Ashton’s schedules exist for the common drugs, including alprazolam, lorazepam, clonazepam, temazepam and zolpidem. Whether to substitute at all remains a physician’s decision against the person’s history, and for a drug that is already long-acting, such as clonazepam, the case rests mainly on diazepam’s small tablet sizes rather than on its half-life.
No Escape Pills
A rule of the Ashton Manual that people skip and regret is the rule against adjuvant drugs. Ashton advises against the sleeping tablets zolpidem, zopiclone and zaleplon during a taper because they have the same actions as benzodiazepines under a different name; a Z-drug for sleep during a benzodiazepine taper is a dose of a GABA-A drug on top of a GABA-A taper. She discourages “escape pills,” extra doses taken to get through a bad day, because they interrupt the smooth decline the whole method depends on. Alcohol is in the same category for the same reason.
What she recommends instead is unglamorous and, in fifteen years of watching tapers here, correct: psychological support, relaxation techniques, sleep habits, exercise and an unhurried schedule. The manual is not against medicine; it is against medicine that reproduces the problem it is meant to solve. That principle, more than any dose table, is what makes the Ashton Manual different from most of what was written in its era, and it is the principle our own program is built on.
Chapter III: Symptoms, and the Long Tail
Chapter III of the Ashton Manual explains why withdrawal symptoms occur and lists them without flinching. Her image is a floodgate: the nervous-system mechanisms the drug had dampened rebound into overactivity when it is removed too fast. The list runs from the psychological, excitability, jumpiness, restlessness, increased anxiety and panic, insomnia, depression, intrusive memories, depersonalization, to the physical, headache, muscle pain and stiffness, tingling, tremor, sweating, sensory hypersensitivity, blurred vision, gastrointestinal upset, palpitations, and, rarely, fits. Then the sentence every reader should underline: different individuals experience different combinations of symptoms; do not expect to get all these symptoms.
On the long tail she is equally direct. Perhaps ten to fifteen percent of long-term benzodiazepine users develop a post-withdrawal syndrome; the symptoms that persist longest are sensory, tinnitus and tingling among them, which may last at least a year and occasionally several years, while protracted anxiety rarely lasts more than a year. And on the question every frightened reader asks, whether the drug has damaged them permanently, the Ashton Manual is unambiguous: there is absolutely no evidence that benzodiazepines cause permanent damage to the brain, nervous system or body. Recovery can be slow, and it happens. Our page on protracted benzodiazepine withdrawal takes that chapter further.
What Has Changed Since 2002
The Ashton Manual was written when the medical mainstream still treated benzodiazepine dependence as rare and the six-week taper as standard. Two things have since moved toward her. In 2020 the FDA required a boxed warning on the entire benzodiazepine class stating that continued use can lead to clinically significant physical dependence, that abrupt discontinuation or rapid dose reduction can be life-threatening, and that some patients experience protracted withdrawal lasting weeks to more than twelve months. That is Chapter I and Chapter III of the manual, restated by the regulator eighteen years later.
In 2025 the American Society of Addiction Medicine, with a coalition of other medical societies, published the first joint clinical practice guideline on benzodiazepine tapering. It recommends reductions of five to ten percent of the current dose every two to four weeks, says the taper should typically not exceed twenty-five percent in any two weeks, advises slowing further at low doses, and states that a full taper may take months to years.
That is slower than Ashton’s own worked examples, which is the direction she would have expected, and it treats switching to a longer-acting benzodiazepine as an option to consider rather than a default, which is a genuine difference from the manual. Read the manual for the method and the guideline for the current numbers; a physician reads both.
How We Use the Ashton Manual Here
I will describe how the Ashton Manual is used at Holistic Sanctuary and then say where the claim stops. Programs here for benzodiazepine dependence are built around twelve to sixteen weeks in residence, one guest to one clinical team, with a physician managing the taper and licensed nurses present twenty-four hours a day. The taper follows Ashton’s method and the 2025 guideline’s numbers, gradual and individualized, with the decision about diazepam substitution made by the physician against your history rather than by a forum.
What the manual could not offer its readers, because they were at home with a general practitioner who had never heard of it, is the thing we can: a physician who sees you every day and can hold, slow or adjust the same day a cut goes wrong.
What we do not do follows the manual too. There is no group therapy here, and no talk therapy in place of medicine. There are no escape pills, no Z-drugs for sleep, no strategy of replacing one dependence-forming medication with another as the treatment, and no alcohol. There is no psychobabble. The Ashton Manual treats benzodiazepine withdrawal as a physiological process that needs time, and fifteen years of doing exactly this, one guest at a time, have taught us the same thing.
Where Ashton stops and we go further is the body. The manual says a good diet, exercise and relaxation; here that means organic food with no seed oils and no processed food, morning yoga, daily massage and reiki, and the Brain Repair IV protocol, a proprietary intravenous protocol our founder developed for exactly this work, running side by side with red light therapy, infrared sauna and NAD, whose evidence and limits are set out honestly on the timeline page.
Every guest is screened before anything is administered: bloodwork, blood pressure, an EKG, a stress test and an echocardiogram reviewed by our medical director. Every guest sleeps in a private oceanfront suite.
Where the claim stops: we do not claim to change anyone’s biology, we do not publish a success percentage, and we do not promise that your taper will be finished in twelve weeks. What we can say is that the program is designed around that window, that it is built on the Ashton Manual’s method, and that a slower, smoother, supervised taper in a place built for it is, in my experience, the version that holds. For the structure of treatment, read how benzodiazepine treatment is built here; for the pillar, benzodiazepine withdrawal. Admission is by medical clearance.
Frequently Asked Questions
What is the Ashton Manual?
The Ashton Manual is Benzodiazepines: How They Work and How to Withdraw, written by Professor Heather Ashton of Newcastle University from twelve years running a benzodiazepine withdrawal clinic. First written in 1999, revised in 2002 and supplemented in 2011, it explains how benzodiazepines cause dependence, gives an equivalence table, sets out slow individualized tapering with diazepam substitution, and describes withdrawal symptoms and the protracted syndrome. It is free on benzo.org.uk.
How fast does the Ashton Manual say to taper?
Ashton says the rate is an individual matter and that a six-week taper is much too fast. Her worked example from 40 mg of diazepam reduces by 2 mg every one to two weeks to 20 mg, then by 1 mg every week or two, taking thirty to sixty weeks, and she notes many people take a year or more. The 2025 ASAM guideline is slower still: five to ten percent every two to four weeks.
Why does the Ashton Manual recommend switching to Valium?
Because diazepam’s half-life of up to two hundred hours gives a smooth fall in blood level, where short-acting drugs like Xanax and Ativan rise and fall with every dose, and because diazepam’s scored 2 mg tablets allow 1 mg steps. The substitution is done gradually under a physician, never as a single swap, and whether to do it at all is a medical decision.
Is the Ashton Manual still valid?
Its method has been vindicated. The FDA’s 2020 boxed warning restates its warnings about dependence, abrupt discontinuation and protracted withdrawal, and the 2025 ASAM joint guideline recommends an even slower taper. The guideline treats switching to a longer-acting benzodiazepine as an option rather than a default, which is the main difference from the manual.
What does the Ashton Manual say about protracted withdrawal?
That perhaps ten to fifteen percent of long-term users develop a post-withdrawal syndrome, that sensory symptoms such as tinnitus and tingling last longest and may persist a year or occasionally several, that protracted anxiety rarely lasts more than a year, and that there is no evidence benzodiazepines cause permanent damage to the brain or body.
How does Holistic Sanctuary use the Ashton Manual?
As the method for a physician-managed, individualized taper adjusted daily within a twelve-to-sixteen-week residential program, with the 2025 guideline’s numbers, no escape pills or Z-drugs, no group or talk therapy, medical screening before admission, and the Brain Repair IV protocol alongside red light therapy, infrared sauna, NAD, massage, reiki and yoga. No outcome is promised.
References
- Ashton H. Benzodiazepines: How They Work and How to Withdraw (the Ashton Manual). Revised August 2002; Supplement April 2011. benzo.org.uk
- Ashton H. The Ashton Manual, Chapter I: The benzodiazepines: what they do in the body. benzo.org.uk
- Ashton H. The Ashton Manual, Chapter II: How to withdraw from benzodiazepines after long-term use. benzo.org.uk
- Ashton H. The Ashton Manual, Chapter III: Benzodiazepine withdrawal symptoms, acute and protracted. benzo.org.uk
- Royal College of Physicians. Chrystal Heather Ashton. Inspiring Physicians (Munk’s Roll). history.rcp.ac.uk
- Chrystal Heather Ashton, obituary. The Lancet. 2019. thelancet.com
- U.S. Food and Drug Administration. FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class. 2020. fda.gov
- Brunner E, et al. Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits. J Gen Intern Med. 2025. link.springer.com
- American Society of Addiction Medicine. Benzodiazepine Tapering guideline page. asam.org
- Vinkers CH, Olivier B. Mechanisms underlying tolerance after long-term benzodiazepine use. Adv Pharmacol Sci. 2012. pubmed.ncbi.nlm.nih.gov
- Pétursson H. The benzodiazepine withdrawal syndrome. Addiction. 1994;89(11):1455–1459. pubmed.ncbi.nlm.nih.gov
Medical disclaimer: this page is general information about the Ashton Manual and is not medical advice or a taper schedule. Do not stop, reduce, or substitute a prescribed benzodiazepine without a physician; abrupt discontinuation can be life-threatening. Holistic Sanctuary does not diagnose, treat, or cure disease; individual results vary and no outcome is promised. In an emergency call 911. If you are thinking about suicide, call or text 988.
